Cita APA (7a ed.)

Kiga, K., Tan, X., Ibarra-Chávez, R., Watanabe, S., Aiba, Y., Sato’o, Y., . . . Cui, L. (2020). Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Nature Portfolio.

Cita Chicago Style (17a ed.)

Kiga, Kotaro, et al. Development of CRISPR-Cas13a-based Antimicrobials Capable of Sequence-specific Killing of Target Bacteria. Nature Portfolio, 2020.

Cita MLA (8a ed.)

Kiga, Kotaro, et al. Development of CRISPR-Cas13a-based Antimicrobials Capable of Sequence-specific Killing of Target Bacteria. Nature Portfolio, 2020.